Skip to content
value.today

CareDx, Inc vs Dr. Lal Path Labs Ltd.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Dr. Lal Path Labs Ltd. is the larger company by market value: $3.6 B against $3.4 B for CareDx, Inc, 1.1 times as much (market caps of Oct 19, 2026 for CareDx, Inc and Nov 20, 2026 for Dr. Lal Path Labs Ltd.).
  • CareDx, Inc had more revenue: $380 M in the year to December 2025 against $261 M for Dr. Lal Path Labs Ltd. in the year to March 2022.
  • Dr. Lal Path Labs Ltd. made a net profit of $43 M, while CareDx, Inc made a net loss of $21 M.
  • Dr. Lal Path Labs Ltd. keeps more of each dollar of sales: a net margin of 16.5% against -5.6% for CareDx, Inc.
  • Dr. Lal Path Labs Ltd. employs more people: 3,923 against 645 at CareDx, Inc. Each employee brings in about $588,837 of revenue at CareDx, Inc and $66,531 at Dr. Lal Path Labs Ltd.
  • On price to earnings, Dr. Lal Path Labs Ltd. trades at 84.5× and CareDx, Inc at 26.1×: investors pay more for each dollar of Dr. Lal Path Labs Ltd.'s profit.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0581171752342020202120222023202420252026CareDx, Inc 101Dr. Lal Path Labs Ltd. 203

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025CareDx, Inc $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureCareDx, Inc
CDNA · #4,671 in the world
Dr. Lal Path Labs Ltd.
LALPATHLAB.NS · #4,436 in the world
Profile
Country🇺🇸 USA🇮🇳 India
SectorHealthcareHealthcare
IndustryDiagnostics and ResearchDiagnostics and Research
Founded19981949
Size
Market cap$3.4 B$3.6 B
Revenue$380 M$261 M
Net income$-21 M$43 M▲ best
Employees6453,923
Valuation
P/E ratio26.1×84.5×
Price to sales6.8×13.9×
Price to book11.1×18.8×
Free cash flow yield-0.2%—
Profitability
Operating margin-8.1%—
Net margin-5.6%—
Return on equity-6.3%—
Growth
Revenue growth13.8%—
Revenue growth, 3 years a year5.7%—
Shareholder returns
Shareholder yield2.6%—
Altman Z-score zonesafe—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Nov 2026

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, CareDx, Inc or Dr. Lal Path Labs Ltd.?

Dr. Lal Path Labs Ltd. is the larger company by market value: $3.6 B against $3.4 B for CareDx, Inc, 1.1 times as much (market caps of Oct 19, 2026 for CareDx, Inc and Nov 20, 2026 for Dr. Lal Path Labs Ltd.).

Which makes more money, CareDx, Inc or Dr. Lal Path Labs Ltd.?

CareDx, Inc had more revenue: $380 M in the year to December 2025 against $261 M for Dr. Lal Path Labs Ltd. in the year to March 2022. Dr. Lal Path Labs Ltd. made a net profit of $43 M, while CareDx, Inc made a net loss of $21 M.

Which is more profitable, CareDx, Inc or Dr. Lal Path Labs Ltd.?

Dr. Lal Path Labs Ltd. keeps more of each dollar of sales: a net margin of 16.5% against -5.6% for CareDx, Inc.

Which has more employees, CareDx, Inc or Dr. Lal Path Labs Ltd.?

Dr. Lal Path Labs Ltd. employs more people: 3,923 against 645 at CareDx, Inc. Each employee brings in about $588,837 of revenue at CareDx, Inc and $66,531 at Dr. Lal Path Labs Ltd.

Is CareDx, Inc cheaper than Dr. Lal Path Labs Ltd.?

On price to earnings, Dr. Lal Path Labs Ltd. trades at 84.5× and CareDx, Inc at 26.1×: investors pay more for each dollar of Dr. Lal Path Labs Ltd.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.

Sources#

Every figure on this page comes from these, with the date shown next to it.